TQ Therapeutics

Regenerative Medicine · Biotechnology

Overview

Our CELLfinity platform is delivering safe in vivo cell & gene therapies that is based on our proprietary EXiVO approach, without abandoning the advantages of autologous cell therapy.

Funding and backers

Latest round
Venture round
Apr 2025 · 18 mo ago
Backers
1
High-Tech Gründerfonds
The money's age
Due for its next round
18 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 7, 2025 Raised a round Venture round Aug 22, 2024 Raised a round Venture round 2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Apr 2025 — — handelsregister.de
Venture round Aug 2024 — — handelsregister.de
Registers and programsofficial lists and records that name the company
Legal entity TQ Therapeutics GmbH its site
Registered 5 Oct 2023
Backed byfrom the funds' portfolios and accelerator catalogs
High-Tech Gründerfonds fund
Investors in similar startupsfunds that back the companies most like this one
Kleiner Perkins
backs Arsenal Bio
SFC Capital
backs Avigen logo
BGF
backs Cellular Origins
ARCH Venture Partners
backs Arsenal Bio
Hitachi Ventures
backs Arsenal Bio
OrbiMed
backs Cellipont
Similar startupsby what they do, their industry and backers
Celaid Therapeutics
セレイドセラピューティクス - 細胞治療(造血幹細胞). Change the futurewith cell therapy.
Cellipont
Advance your cell therapy with Cellipont Bioservices, a leading cell therapy CDMO, offering tailored development, analytics, and cGMP…
Blue Marlin TherapeuticsVenture round $100k · 12 mo ago · Founded 2025
Building programmable in vivo immune-cell therapies across oncology and autoimmune disease.
Avigen logo
Avigen develops cellular avidity tools for immunotherapy and cell therapy R&D, helping identify potent and safe lead drug candidates faster.
Arsenal Bio
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Cellular OriginsVenture round · 11 mo ago · Founded 2022 · 51-200 employees
Constellation® is an automated cell therapy manufacturing platform that enables scalable, flexible production without therapy redevelopment…

Financials

Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 — Details
Venture - Series Unknown 2024 — Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
High-Tech GründerfondsVia a fund
516 portfolio companies
Report a mistake

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Munich Germany
HQ
company site
Planegg Germany
Regional office
TQ Therapeutics GmbH
82152 Planegg Germany
company site